Overview
The purpose of this study is to evaluate the efficacy and safety of KH001 in subjects with dentin hypersensitivity.
Description
The study will consist of a screening period, a treatment period, and a follow-up period. The total duration of the study for each subject will be approximately 8 to 12 weeks. All subjects will be randomly assigned in a 1:1:1 ratio, with Group A, Group B and Group C.
Eligibility
Inclusion Criteria:
- Is at least 18 years old by the time of the screening visit
- Is in good general health as determined by the investigator
- Has at least 2 non-adjacent teeth and is diagnosed with hypersensitive
Exclusion Criteria:
- Is allergic to the active drug substance or other excipients used in the investigational product
- Has any history of alcohol or drug abuse
- Has received any treatment related to dentin hypersensitivity within 8 weeks prior to the screening visit
- Is jedged by the investigator as ineligible for participation for other reasons